Article Details
Retrieved on: 2023-01-04 04:15:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
FDA approves Roche's Lunsumio, a first-in-class bispecific antibody, to treat people wi.. GL. More news. Analyst Recommendations on ROCHE HOLDING AG ...
Article found on: www.marketscreener.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here